Anti-cancer vaccine therapy for hematologic malignancies: An evolving era.

MLA

Nahas, Myrna R., et al. “Anti-Cancer Vaccine Therapy for Hematologic Malignancies: An Evolving Era.” Blood Reviews, vol. 32, no. 4, July 2018, pp. 312–25. EBSCOhost, https://doi.org/10.1016/j.blre.2018.02.002.

APA

Nahas, M. R., Rosenblatt, J., Lazarus, H. M., & Avigan, D. (2018). Anti-cancer vaccine therapy for hematologic malignancies: An evolving era. Blood Reviews, 32(4), 312–325. https://doi.org/10.1016/j.blre.2018.02.002

Chicago

Nahas, Myrna R, Jacalyn Rosenblatt, Hillard M Lazarus, and David Avigan. 2018. “Anti-Cancer Vaccine Therapy for Hematologic Malignancies: An Evolving Era.” Blood Reviews 32 (4): 312–25. doi:10.1016/j.blre.2018.02.002.